Sound Income Strategies’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-13
| Closed | -$90 | – | 1466 |
|
2023
Q4 | $90 | Hold |
13
| – | – | ﹤0.01% | 1283 |
|
2023
Q3 | $122 | Hold |
13
| – | – | ﹤0.01% | 1117 |
|
2023
Q2 | $282 | Hold |
13
| – | – | ﹤0.01% | 1065 |
|
2023
Q1 | $359 | Hold |
13
| – | – | ﹤0.01% | 1012 |
|
2022
Q4 | $472 | Hold |
13
| – | – | ﹤0.01% | 917 |
|
2022
Q3 | $3K | Hold |
13
| – | – | ﹤0.01% | 672 |
|
2022
Q2 | $3K | Hold |
13
| – | – | ﹤0.01% | 687 |
|
2022
Q1 | $3K | Hold |
13
| – | – | ﹤0.01% | 701 |
|
2021
Q4 | $2K | Hold |
13
| – | – | ﹤0.01% | 741 |
|
2021
Q3 | $3K | Hold |
13
| – | – | ﹤0.01% | 665 |
|
2021
Q2 | $3K | Hold |
13
| – | – | ﹤0.01% | 697 |
|
2021
Q1 | $3.54K | Hold |
13
| – | – | ﹤0.01% | 675 |
|
2020
Q4 | $5K | Hold |
13
| – | – | ﹤0.01% | 595 |
|
2020
Q3 | $3K | Hold |
13
| – | – | ﹤0.01% | 636 |
|
2020
Q2 | $4K | Hold |
13
| – | – | ﹤0.01% | 554 |
|
2020
Q1 | $3K | Hold |
13
| – | – | ﹤0.01% | 549 |
|
2019
Q4 | $6K | Sell |
13
-3
| -19% | -$1.39K | ﹤0.01% | 441 |
|
2019
Q3 | $5K | Buy |
+16
| New | +$5K | ﹤0.01% | 440 |
|